Polypeptide GalNac Transferase 10/GALNT10 Antibody [Alexa Fluor® 350]

• Reactivity: Hu, Mu
• Applications: WB, IHC
• Clonality: Polyclonal
• Host: Sheep
• Conjugate: Alexa Fluor 350

Polypeptide GalNac Transferase 10/GALNT10 Antibody [Alexa Fluor® 350] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant human Polypeptide GalNac Transferase 10/GALNT10
  Leu71-Asn603
  Accession # Q86SR1
• Specificity: Detects human and mouse Polypeptide GalNac Transferase 10/GALNT10 in Western blots. In direct ELISA, less than 1% cross-reactivity with recombinant human (rh) GALNT1 and rhGALNT4 is observed.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Sheep
• Purity: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Immunohistochemistry
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide
• Purity: Antigen Affinity-purified

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Polypeptide GalNac Transferase 10/GALNT10 Antibody [Alexa Fluor® 350]

• DKFZp586H0623
• EC 2.4.1.41
• FLJ00205
• FLJ11715
• GalNAc transferase 10
• GALNACT10
• GalNAc-T10
• GALNT10
• Polypeptide GalNAc transferase 10
• polypeptide N-acetylgalactosaminyltransferase 10
• PPGALNACT10
• pp-GaNTase 10
• PPGANTASE10
• Protein-UDP acetylgalactosaminyltransferase 10
• UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10
• UDP-N-acetyl-alpha-D-galactosamine:polypeptideN-acetylgalactosaminyltransferase 10 (GalNAc-T10)

Background

GALNT10 (N-Acetyl-Galactosaminyl Transferase 10; also UDP-Acetylgalactosaminyltransferase 10 and ppGalNAc-T10) is a member of the GalNAC transferase subfamily, glycosyltransferase 2 family of enzymes. It is widely expressed, being found in intestine, pancreas, thyroid and spleen. GALNT10 is found in the Golgi apparatus, and catalyzes the transfer of UDP-GalNAc onto either a Ser or Thr residue on a previously glycosylated peptide/polypeptide backbone. Human GALNT2 is a 603 amino acid (aa) type II transmembrane glycoprotein. It contains an 11 aa N-terminal cytoplasmic region and a 572 aa extracellular domain (aa 32-603). The ECD possesses two key parts, a catalytic region with two catalytic subdomains (aa 144-253 and 311-373), and a ricin B-type lectin domain that binds carbohydrates (aa 458-590). These two distinct domains have unique but complimentary properties. By itself, an active catalytic domain can do no more than place a GalNAc residue immediately adjacent to an existing C-terminal GalNAC residue. Alternatively, if the lectin domain is involved, this domain may recognize (bind to) any number of existing glycosylation sites, allowing for the subsequent attachment of GalNAc by the catalytic site onto a Ser or Thr residue quite distant from the initial lectin domain:CHO recognition site. There are at least three potential splice form variants. One shows a deletion of aa 190-251, a second contains a 13 aa substitution for aa 354-366, and a third possesses a 23 aa substitution for aa 1-352 coupled to a three aa substitution for Asn389. Over aa 71-603, human GALNT10 shares 96% aa sequence identity with mouse GALNT10.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.